Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Gross Profit (2016 - 2025)

Marimed has reported Gross Profit over the past 15 years, most recently at $10.5 million for Q4 2025.

  • Quarterly Gross Profit fell 17.02% to $10.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.0 million through Dec 2025, down 7.62% year-over-year, with the annual reading at $57.9 million for FY2025, 7.56% down from the prior year.
  • Gross Profit was $10.5 million for Q4 2025 at Marimed, down from $16.4 million in the prior quarter.
  • Over five years, Gross Profit peaked at $19.4 million in Q2 2021 and troughed at $10.5 million in Q4 2025.
  • The 5-year median for Gross Profit is $16.3 million (2022), against an average of $15.8 million.
  • Year-over-year, Gross Profit soared 215.13% in 2021 and then decreased 26.92% in 2024.
  • A 5-year view of Gross Profit shows it stood at $15.5 million in 2021, then grew by 2.08% to $15.8 million in 2022, then grew by 9.52% to $17.3 million in 2023, then fell by 26.92% to $12.7 million in 2024, then decreased by 17.02% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Gross Profit are $10.5 million (Q4 2025), $16.4 million (Q3 2025), and $16.0 million (Q2 2025).